
Cerebral Cortex, Benzodiazepines, Clinical Trials as Topic, Basal Ganglia Diseases, Dopamine Agents, Humans, Anticonvulsants, Neurodegenerative Diseases, Antidepressive Agents, Cholinergic Antagonists
Cerebral Cortex, Benzodiazepines, Clinical Trials as Topic, Basal Ganglia Diseases, Dopamine Agents, Humans, Anticonvulsants, Neurodegenerative Diseases, Antidepressive Agents, Cholinergic Antagonists
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
